5 of 193 shown

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

There are two charts here because there are two different amounts. A lobbying firm reports income: what it was paid. A company that lobbies for itself reports expenses: what it spent, under one of three accounting methods it picks itself. Both appear under this company, and they are not the same measurement — so they are never added, not in a bar and not in a total.

Reported income: what lobbying firms reported receiving from this company's clients, per quarter.

Reported expenses: what this company reported spending on its own lobbying, per quarter, under the accounting method it picked itself.

Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.

Reported income

Q1Q2Q3Q4
$0$500k$1M2012: $0 Q1, $120k Q2, $120k Q3, $120k Q420122013: $120k Q1, $120k Q2, $120k Q3, $120k Q420132014: $120k Q1, $120k Q2, $120k Q3, $120k Q420142015: $120k Q1, $120k Q2, $120k Q3, $120k Q420152016: $120k Q1, $120k Q2, $120k Q3, $120k Q420162017: $120k Q1, $120k Q2, $120k Q3, $120k Q420172018: $120k Q1, $120k Q2, $120k Q3, $120k Q420182019: $200k Q1, $220k Q2, $220k Q3, $220k Q420192020: $220k Q1, $220k Q2, $220k Q3, $220k Q420202021: $220k Q1, $220k Q2, $220k Q3, $220k Q420212022: $220k Q1, $220k Q2, $220k Q3, $220k Q420222023: $220k Q1, $220k Q2, $220k Q3, $220k Q420232024: $150k Q1, $150k Q2, $180k Q3, $180k Q420242025: $180k Q1, $180k Q2, $180k Q3, $210k Q420252026: $230k Q1, $230k Q2, $230k Q32026

Reported expenses

Q1Q2Q3Q4
$0$2.5M$5M2012: $0 Q1, $0 Q2, $0 Q3, $0 Q420122013: $0 Q1, $0 Q2, $0 Q3, $0 Q420132014: $0 Q1, $0 Q2, $0 Q3, $0 Q420142015: $0 Q1, $0 Q2, $0 Q3, $0 Q420152016: $0 Q1, $0 Q2, $0 Q3, $0 Q420162017: $0 Q1, $0 Q2, $0 Q3, $0 Q420172018: $0 Q1, $0 Q2, $0 Q3, $0 Q420182019: $0 Q1, $0 Q2, $0 Q3, $0 Q420192020: $0 Q1, $0 Q2, $0 Q3, $0 Q420202021: $0 Q1, $160k Q2, $160k Q3, $90k Q420212022: $460k Q1, $530k Q2, $490k Q3, $640k Q420222023: $630k Q1, $640k Q2, $640k Q3, $690k Q420232024: $510k Q1, $520k Q2, $470k Q3, $540k Q420242025: $380k Q1, $370k Q2, $410k Q3, $490k Q420252026: $470k Q1, $490k Q2, $550k Q32026

Recent activity

Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.

11 superseded versions left out of the quarterly sums, listed here.

5 of 193 filings
The most recently posted lobbying filings for JAZZ
RegistrantFilingAmountPosted RegistrantAmountFilingAll amountsPosted
AVENUE SOLUTIONSfor JAZZ PHARMACEUTICALS, INC.3rd Quarter - Report3rd Quarter 2026$50,000incomeposted Oct 20, 2026 (LD-2 at lda.gov)Oct 20, 2026 (LD-2 at lda.gov)AVENUE SOLUTIONSfor JAZZ PHARMACEUTICALS, INC.$50,000income · Oct 203rd Quarter - Report3rd Quarter 2026$50,000incomeOct 20, 2026 (LD-2 at lda.gov)
JAZZ PHARMACEUTICALS, INC.for JAZZ PHARMACEUTICALS, INC.3rd Quarter - Report3rd Quarter 2026$550,000expenses (A)posted Oct 20, 2026 (LD-2 at lda.gov)Oct 20, 2026 (LD-2 at lda.gov)JAZZ PHARMACEUTICALS, INC.for JAZZ PHARMACEUTICALS, INC.$550,000expenses (A) · Oct 203rd Quarter - Report3rd Quarter 2026$550,000expenses (A)Oct 20, 2026 (LD-2 at lda.gov)
TARPLIN, DOWNS & YOUNG, LLCfor JAZZ PHARMACEUTICALS INC.3rd Quarter - Report3rd Quarter 2026$80,000incomeposted Oct 20, 2026 (LD-2 at lda.gov)Oct 20, 2026 (LD-2 at lda.gov)TARPLIN, DOWNS & YOUNG, LLCfor JAZZ PHARMACEUTICALS INC.$80,000income · Oct 203rd Quarter - Report3rd Quarter 2026$80,000incomeOct 20, 2026 (LD-2 at lda.gov)
THE NICKLES GROUP, LLCfor JAZZ PHARMACEUTICALS, INC.3rd Quarter - Report3rd Quarter 2026$50,000incomeposted Oct 19, 2026 (LD-2 at lda.gov)Oct 19, 2026 (LD-2 at lda.gov)THE NICKLES GROUP, LLCfor JAZZ PHARMACEUTICALS, INC.$50,000income · Oct 193rd Quarter - Report3rd Quarter 2026$50,000incomeOct 19, 2026 (LD-2 at lda.gov)
TIBER CREEK GROUPfor JAZZ PHARMACEUTICALS3rd Quarter - Report3rd Quarter 2026$50,000incomeposted Oct 18, 2026 (LD-2 at lda.gov)Oct 18, 2026 (LD-2 at lda.gov)TIBER CREEK GROUPfor JAZZ PHARMACEUTICALS$50,000income · Oct 183rd Quarter - Report3rd Quarter 2026$50,000incomeOct 18, 2026 (LD-2 at lda.gov)

The link between the client names above and JAZZ is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.